Symbols / RVPH Stock $0.41 +0.65% Reviva Pharmaceuticals Holdings, Inc.

Healthcare • Biotechnology • United States • OQB
RVPH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country OQB · United States
Market Cap 5.13M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $0.40
Price $0.41
Change 0.65%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest RVPH news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
20.20
-34.41%
30.80
-22.04%
39.50
+39.94%
28.23
Research And Development
11.71
-48.89%
22.91
-27.09%
31.42
+37.38%
22.87
Selling General And Administration
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
General And Administrative Expense
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
Other Gand A
8.49
+7.60%
7.89
-2.38%
8.08
+50.85%
5.36
Total Expenses
20.20
-34.41%
30.80
-22.04%
39.50
+39.94%
28.23
Operating Income
-20.20
+34.41%
-30.80
+22.04%
-39.50
-39.94%
-28.23
Total Operating Income As Reported
-20.20
+34.41%
-30.80
+22.04%
-39.50
-39.94%
-28.23
EBITDA
-19.83
+33.63%
-29.88
+23.79%
-39.21
-38.90%
-28.23
Normalized EBITDA
-19.92
+34.89%
-30.60
+21.48%
-38.97
-39.01%
-28.03
Reconciled Depreciation
—
—
—
—
EBIT
-19.83
+33.63%
-29.88
+23.79%
-39.21
-38.90%
-28.23
Total Unusual Items
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Total Unusual Items Excluding Goodwill
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Net Income
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Pretax Income
-19.85
+33.62%
-29.90
+23.81%
-39.24
-38.96%
-28.24
Net Non Operating Interest Income Expense
0.30
-13.10%
0.34
-5.98%
0.36
+99.50%
0.18
Interest Expense Non Operating
0.01
-27.55%
0.02
-45.15%
0.03
—
Net Interest Income
0.30
-13.10%
0.34
-5.98%
0.36
+99.50%
0.18
Interest Expense
0.01
-27.55%
0.02
-45.15%
0.03
—
Interest Income Non Operating
0.31
-13.84%
0.36
-9.30%
0.40
+117.95%
0.18
Interest Income
0.31
-13.84%
0.36
-9.30%
0.40
+117.95%
0.18
Other Income Expense
0.06
-89.93%
0.56
+630.52%
-0.10
+46.10%
-0.19
Other Non Operating Income Expenses
-0.03
+79.52%
-0.16
-219.84%
0.13
—
Gain On Sale Of Security
0.09
-87.60%
0.72
+400.00%
-0.24
-22.86%
-0.19
Tax Provision
0.02
-3.20%
0.02
+15.13%
0.02
-18.42%
0.02
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.02
-87.60%
0.15
+400.00%
-0.05
-22.86%
-0.04
Net Income Including Noncontrolling Interests
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income From Continuing Operation Net Minority Interest
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income From Continuing And Discontinued Operation
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Net Income Continuous Operations
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Normalized Income
-19.94
+34.61%
-30.49
+21.98%
-39.07
-39.01%
-28.11
Net Income Common Stockholders
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Diluted EPS
-5.48
+69.56%
-18.00
+45.45%
-33.00
-32.00%
-25.00
Basic EPS
-5.48
+69.56%
-18.00
+45.45%
-33.00
-32.00%
-25.00
Basic Average Shares
3.63
+118.89%
1.66
+39.29%
1.19
+21.94%
0.98
Diluted Average Shares
3.63
+118.89%
1.66
+39.29%
1.19
+21.94%
0.98
Diluted NI Availto Com Stockholders
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Total Other Finance Cost
—
—
—
-0.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
15.92
+2.71%
15.50
-34.59%
23.70
+25.24%
18.92
Current Assets
15.10
+2.86%
14.68
-38.05%
23.70
+25.24%
18.92
Cash Cash Equivalents And Short Term Investments
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Cash And Cash Equivalents
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Cash Equivalents
13.23
+8.40%
12.20
-45.06%
22.21
—
Cash Financial
1.21
-4.92%
1.27
+10.13%
1.16
—
Prepaid Assets
0.00
-100.00%
0.54
+590.47%
0.08
-80.61%
0.40
Other Current Assets
0.66
-0.26%
0.67
+161.72%
0.25
-36.94%
0.40
Total Non Current Assets
0.82
+0.00%
0.82
0.00
0.00
Non Current Prepaid Assets
0.82
+0.00%
0.82
0.00
—
Total Liabilities Net Minority Interest
7.28
-50.47%
14.69
-18.30%
17.98
+70.78%
10.53
Current Liabilities
7.28
-50.17%
14.60
-14.98%
17.18
+72.41%
9.96
Payables And Accrued Expenses
6.38
-52.75%
13.51
-16.70%
16.22
+72.56%
9.40
Payables
3.01
-52.11%
6.28
+63.24%
3.85
+9.34%
3.52
Accounts Payable
3.01
-52.11%
6.28
+63.24%
3.85
+9.34%
3.52
Current Accrued Expenses
3.37
-53.30%
7.22
-41.59%
12.37
+110.43%
5.88
Pensionand Other Post Retirement Benefit Plans Current
0.49
-23.55%
0.64
-33.70%
0.96
+69.77%
0.56
Current Debt And Capital Lease Obligation
0.41
-11.19%
0.46
—
—
Current Debt
0.41
-11.19%
0.46
—
—
Other Current Borrowings
0.41
-11.19%
0.46
—
—
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.09
-88.97%
0.81
+42.16%
0.57
Stockholders Equity
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Common Stock Equity
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Capital Stock
0.01
+150.21%
0.00
+66.83%
0.00
+36.53%
0.00
Common Stock
0.01
+150.21%
0.00
+66.83%
0.00
+36.53%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
5.87
+152.17%
2.33
+66.84%
1.40
+36.54%
1.02
Ordinary Shares Number
5.87
+152.17%
2.33
+66.84%
1.40
+36.54%
1.02
Additional Paid In Capital
192.77
+16.78%
165.08
+17.86%
140.07
+35.35%
103.49
Retained Earnings
-184.14
-12.09%
-164.27
-22.27%
-134.35
-41.29%
-95.09
Total Equity Gross Minority Interest
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Total Capitalization
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Working Capital
7.83
+9462.46%
0.08
-98.75%
6.53
-27.19%
8.96
Invested Capital
9.05
+612.55%
1.27
-77.78%
5.72
-31.87%
8.39
Total Debt
0.41
-11.19%
0.46
—
—
Net Tangible Assets
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Tangible Book Value
8.65
+964.23%
0.81
-85.79%
5.72
-31.87%
8.39
Derivative Product Liabilities
0.00
-100.00%
0.09
-88.97%
0.81
+42.16%
0.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Cash Flow From Continuing Operating Activities
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Net Income From Continuing Operations
-19.86
+33.60%
-29.92
+23.79%
-39.26
-38.92%
-28.26
Depreciation Amortization Depletion
—
—
—
—
Depreciation
—
—
—
—
Depreciation And Amortization
—
—
—
—
Other Non Cash Items
—
—
—
—
Stock Based Compensation
2.23
+36.65%
1.63
-52.24%
3.41
+1831.34%
0.18
Operating Gains Losses
-0.09
+87.60%
-0.72
-400.00%
0.24
+22.86%
0.19
Gain Loss On Investment Securities
-0.09
+87.60%
-0.72
-400.00%
0.24
+22.86%
0.19
Change In Working Capital
-6.87
-51.36%
-4.54
-162.30%
7.28
-18.43%
8.93
Change In Prepaid Assets
0.54
+132.02%
-1.69
-2489.47%
0.07
-94.60%
1.31
Change In Payables And Accrued Expense
-7.41
-160.58%
-2.84
-139.43%
7.21
-5.31%
7.62
Change In Accrued Expense
-4.00
+22.04%
-5.14
-174.59%
6.88
+49.45%
4.61
Change In Payable
-3.41
-248.73%
2.29
+596.75%
0.33
-89.08%
3.01
Change In Account Payable
-3.41
-248.73%
2.29
+596.75%
0.33
-89.08%
3.01
Financing Cash Flow
25.56
+8.05%
23.65
-28.70%
33.17
+325.69%
7.79
Cash Flow From Continuing Financing Activities
25.56
+8.05%
23.65
-28.70%
33.17
+325.69%
7.79
Net Issuance Payments Of Debt
-0.05
-111.19%
0.46
0.00
0.00
Issuance Of Debt
0.41
-58.35%
0.98
+46.35%
0.67
0.00
Repayment Of Debt
-0.46
+11.68%
-0.52
+22.28%
-0.67
0.00
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
0.41
-58.35%
0.98
+46.35%
0.67
0.00
Short Term Debt Payments
-0.46
+11.68%
-0.52
+22.28%
-0.67
0.00
Net Short Term Debt Issuance
-0.05
-111.19%
0.46
0.00
0.00
Net Common Stock Issuance
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
Proceeds From Stock Option Exercised
6.98
+4681822.82%
0.00
-100.00%
5.68
+29836.99%
0.02
Changes In Cash
0.96
+109.73%
-9.89
-304.04%
4.85
+143.41%
-11.17
Beginning Cash Position
13.48
-42.33%
23.37
+26.18%
18.52
-37.62%
29.69
End Cash Position
14.44
+7.14%
13.48
-42.33%
23.37
+26.18%
18.52
Free Cash Flow
-24.59
+26.68%
-33.54
-18.43%
-28.32
-49.39%
-18.96
Interest Paid Supplemental Data
0.01
-27.55%
0.02
-39.60%
0.03
0.00
Income Tax Paid Supplemental Data
0.00
-1.40%
0.00
-82.70%
0.02
+19.84%
0.02
Change In Interest Payable
—
—
—
—
Common Stock Issuance
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
Issuance Of Capital Stock
18.63
-19.67%
23.19
-15.64%
27.49
+253.69%
7.77
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category